VEGFR Tyrosine Kinase Inhibitor

Mapping Intimacies ◽

10.32388/645sey ◽

2020 ◽

Author(s):

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

VEGFR tyrosine kinase inhibitor II (VRI) induced vascular insufficiency in zebrafish as a model for studying vascular toxicity and vascular preservation

Toxicology and Applied Pharmacology ◽

10.1016/j.taap.2014.09.005 ◽

2014 ◽

Vol 280 (3) ◽

pp. 408-420 ◽

Author(s):

Shang Li ◽

Yuan Ye Dang ◽

Ginny Oi Lam Che ◽

Yiu Wa Kwan ◽

Shun Wan Chan ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Vascular Toxicity ◽

Vascular Insufficiency ◽

Vascular Preservation ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer

Bulletin du Cancer ◽

10.1016/s0007-4551(20)30283-6 ◽

2020 ◽

Vol 107 (5) ◽

pp. eS22-eS27 ◽

Author(s):

Nicolas Epaillard ◽

Audrey Simonaggio ◽

Reza Elaidi ◽

Fouzia Azzouz ◽

Elena Braychenko ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kidney Cancer ◽

Kinase Inhibitor ◽

Phase 2 ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

Acute left ventricular dysfunction induced by a panHER and VEGFR tyrosine kinase inhibitor in a phase I trial

Investigational New Drugs ◽

10.1007/s10637-009-9252-6 ◽

2009 ◽

Vol 28 (3) ◽

pp. 350-352 ◽

Author(s):

Rastislav Bahleda ◽

Christophe Massard ◽

Jean-Charles Soria ◽

Hassan Izzedine ◽

Ariel Cohen ◽

...

Keyword(s):

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Left Ventricular Dysfunction ◽

Phase I Trial ◽

Ventricular Dysfunction ◽

Kinase Inhibitor ◽

Left Ventricular ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

Pharmacokinetics (PK) and tolerability of GW786034, a VEGFR tyrosine kinase inhibitor, after daily oral administration to patients with solid tumors

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3054 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3054-3054 ◽

Author(s):

A. B. Suttle ◽

H. Hurwitz ◽

A. Dowlati ◽

N. Fernando ◽

S. Savage ◽

...

Keyword(s):

Oral Administration ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Solid Tumors ◽

Kinase Inhibitor ◽

Daily Oral Administration ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib

PLoS ONE ◽

10.1371/journal.pone.0066003 ◽

2013 ◽

Vol 8 (6) ◽

pp. e66003 ◽

Author(s):

James R. Bradford ◽

Matthew Farren ◽

Steve J. Powell ◽

Sarah Runswick ◽

Susie L. Weston ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Mrna Expression ◽

Kinase Inhibitor ◽

Rna Seq ◽

Human Tumour ◽

Human Tumour Xenografts ◽

Tumour Xenografts ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

Non-VEGFR Tyrosine Kinase Inhibitor

10.32388/gnr65l ◽

2020 ◽

Author(s):

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

Inflammatory Corneal (Lymph)angiogenesis Is Blocked by VEGFR-Tyrosine Kinase Inhibitor ZK 261991, Resulting in Improved Graft Survival after Corneal Transplantation

Investigative Opthalmology & Visual Science ◽

10.1167/iovs.07-1314 ◽

2008 ◽

Vol 49 (5) ◽

pp. 1836 ◽

Author(s):

Deniz Hos ◽

Felix Bock ◽

Tina Dietrich ◽

Jasmine Onderka ◽

Friedrich E. Kruse ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Graft Survival ◽

Kinase Inhibitor ◽

Corneal Transplantation ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

Detection of Early Antiangiogenic Effects in Human Colon Adenocarcinoma Xenografts: In vivo Changes of Tumor Blood Volume in Response to Experimental VEGFR Tyrosine Kinase Inhibitor

Cancer Research ◽

10.1158/0008-5472.can-03-2619 ◽

2005 ◽

Vol 65 (20) ◽

pp. 9253-9260 ◽

Author(s):

Young Ro Kim ◽

Anna Yudina ◽

JoseLuis Figueiredo ◽

Wilfried Reichardt ◽

Dana Hu-Lowe ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Blood Volume ◽

Kinase Inhibitor ◽

Colon Adenocarcinoma ◽

Human Colon ◽

Human Colon Adenocarcinoma ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

A phase I dose escalation trial of the VEGFR tyrosine kinase inhibitor, PTK787/ ZK222584 (PTK/ZK), used in combination with paclitaxel in patients with advanced solid tumors with pharmacokinetic (PK) analysis

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.14521 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 14521-14521

Author(s):

S. R. Malireddy ◽

E. G. Chiorean ◽

A. Younger ◽

D. Jones ◽

M. Waddell ◽

...

Keyword(s):

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Solid Tumors ◽

Dose Escalation ◽

Kinase Inhibitor ◽

Advanced Solid Tumors ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text

596 The Effect of Rifampin On the Pharmacokinetics of Tivozanib, a Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor

European Journal of Cancer ◽

10.1016/s0959-8049(12)72393-6 ◽

2012 ◽

Vol 48 ◽

pp. 183 ◽

Author(s):

M. Cotreau ◽

D. Subic ◽

L. Massmanian ◽

A. Strahs ◽

D. Vargo

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Vegfr Tyrosine Kinase Inhibitor

Download Full-text